Table 2 Demographic and Baseline characteristics of the subjects eligible for the trial
Characteristics | Placebo | Meratrim |
|---|---|---|
(n = 30) | (n = 30) | |
Sex ((n) male + (n) female) | 14 M + 16 F | 10 M + 20 F |
Age (years) | 39.47 ± 1.73 | 36.63 ± 1.64 |
Height (meters) | 1.65 ± 0.017 | 1.63 ± 0.02 |
Body weight (kg) | 76.56 ± 1.64 | 75.93 ± 1.91 |
Body mass index (kg/m2) | 28.20 ± 0.24 | 28.48 ± 0.25 |
Waist circumference (cm) | 103.30 ± 1.53 | 102.00 ± 1.59 |
Hip circumference (cm) | 108.70 ± 1.88 | 108.60 ± 1.59 |
Waist/Hip ratio | 0.96 ± 0.017 | 0.94 ± 0.013 |
Triglycerides (mg/dL) | 200.50 ± 8.16 | 194.20 ± 8.96 |
Total cholesterol (mg/dL) | 184.90 ± 6.18 | 168.80 ± 5.37 |
LDL (mg/dL) | 108.20 ± 5.97 | 94.67 ± 4.73 |
HDL (mg/dL) | 36.60 ± 0.42 | 35.27 ± 0.51 |
LHR | 2.94 ± 0.15 | 2.68 ± 0.12 |
VLDL (mg/dL) | 40.13 ± 1.67 | 38.83 ± 1.78 |
Fasting blood glucose (mg/dL) | 99.47 ± 1.82 | 95.60 ± 1.99 |